Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

VMD issues product defect recall alert
The recall affects batches of Carprieve 5% w/v Small Animal Solution for Injection.

Recall is a precautionary measure owing to higher than usual impurities.

The Veterinary Medicines Directorate (VMD) has issued a product defect recall alert for Carprieve 5% w/v Small Animal Solution for Injection, manufactured by Norbrook Laboratories Ltd.

A statement reads: 'We wish to make veterinary surgeons aware that Norbrook Laboratories Ltd have initiated a Class 2 recall to veterinarian level for the product Carprieve 5% w/v Small Animal Solution for Injection. This is as a precautionary measure due to higher than usual impurities.

'A health hazard assessment has been completed by the company veterinary surgeon. This concludes that any risk to animal and human health is likely to be low and no greater than expected for this product under normal conditions, as described on the product labelling.'

The recall affects the following batch numbers:

0265-90 
0302-90 
0246-90 
0112-90 
0295-90 
9053-91 
9103-91

The statement continues: 'Norbrook Laboratories Ltd are contacting veterinary surgeons to examine inventory immediately and quarantine products subject to this recall.'

For further information regarding the recall contact Gary Mckee on +44 2830 264435 or email gary.mckee@norbrook.co.uk 

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'